Semanteon Capital Management, LP Adma Biologics, Inc. Call Options Transaction History
Semanteon Capital Management, LP
- $141 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ADMA
# of Institutions
264Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$243 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$220 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$149 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$135 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...